<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font32 { font-size : 32; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font21 { font-size : 21; } .font22 { font-size : 22; } .font23 { font-size : 23; } .font25 { font-size : 25; }</style>
 <body>
  <p>
   <span class="font32">development </span>
   <span class="font25">drug </span>
   <span class="font23">{border-style </span>
   <span class="font23">animal </span>
   <span class="font22">px;} </span>
   <span class="font21">#ffffff;} </span>
   <span class="font19">new </span>
   <span class="font18">antiviral </span>
   <span class="font17">diseases </span>
   <span class="font16">BSL- </span>
   <span class="font16">ST- </span>
   <span class="font16">small </span>
   <span class="font16">support </span>
   <span class="font16">viruses </span>
   <span class="font16">agents </span>
   <span class="font16">antivirals </span>
   <span class="font16">available </span>
   <span class="font16">developing </span>
   <span class="font16">potential </span>
   <span class="font16">research </span>
   <span class="font16">studies </span>
   <span class="font15">FDA </span>
   <span class="font15">SIGA </span>
   <span class="font15">appropriate </span>
   <span class="font15">develop </span>
   <span class="font15">drugs </span>
   <span class="font15">funding </span>
   <span class="font15">government </span>
   <span class="font15">human </span>
   <span class="font15">models </span>
   <span class="font15">pathogens </span>
   <span class="font15">px; </span>
   <span class="font15">viral </span>
   <span class="font15">{font-family </span>
   <span class="font14">biothreat </span>
   <span class="font14">clinical </span>
   <span class="font14">compound </span>
   <span class="font14">disease </span>
   <span class="font14">efficacy </span>
   <span class="font14">emerging </span>
   <span class="font14">font-size </span>
   <span class="font14">information </span>
   <span class="font14">treatment </span>
   <span class="font14">use </span>
   <span class="font14">work </span>
   <span class="font14">approach </span>
   <span class="font14">company </span>
   <span class="font14">double; </span>
   <span class="font14">high </span>
   <span class="font14">necessary </span>
   <span class="font14">product </span>
   <span class="font14">regulatory </span>
   <span class="font14">virus </span>
   <span class="font13">Elsevier </span>
   <span class="font13">RNA </span>
   <span class="font13">Research </span>
   <span class="font13">agencies </span>
   <span class="font13">border-color </span>
   <span class="font13">border-width </span>
   <span class="font13">chemistry </span>
   <span class="font13">companies </span>
   <span class="font13">developed </span>
   <span class="font13">limited </span>
   <span class="font13">need </span>
   <span class="font13">prevent </span>
   <span class="font13">required </span>
   <span class="font13">solid; </span>
   <span class="font13">stage </span>
   <span class="font13">{font-style </span>
   <span class="font13">{font-weight </span>
   <span class="font12">COVID- </span>
   <span class="font12">Department </span>
   <span class="font12">SIGA's </span>
   <span class="font12">United </span>
   <span class="font12">agent </span>
   <span class="font12">biological </span>
   <span class="font12">bold </span>
   <span class="font12">bridge </span>
   <span class="font12">centre </span>
   <span class="font12">contracts </span>
   <span class="font12">countermeasures </span>
   <span class="font12">courier; </span>
   <span class="font12">em; </span>
   <span class="font12">endemic </span>
   <span class="font12">federal </span>
   <span class="font12">genome </span>
   <span class="font12">important </span>
   <span class="font12">market </span>
   <span class="font12">mechanism </span>
   <span class="font12">medicinal </span>
   <span class="font12">model </span>
   <span class="font12">orthopoxvirus </span>
   <span class="font12">pathogen </span>
   <span class="font12">pathogens. </span>
   <span class="font12">possible </span>
   <span class="font12">prevention </span>
   <span class="font12">products </span>
   <span class="font12">pt;} </span>
   <span class="font12">require </span>
   <span class="font12">requires </span>
   <span class="font12">resource </span>
   <span class="font12">significant </span>
   <span class="font12">studies, </span>
   <span class="font12">surrogate </span>
   <span class="font12">therapeutic </span>
   <span class="font12">types </span>
   <span class="font12">using </span>
   <span class="font12">variola </span>
  </p>
 </body>
</html>
